A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus
Status:
Not yet recruiting
Trial end date:
2022-06-18
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to learn about the side effects of LY3502970 when given to
Japanese participants with type 2 diabetes mellitus (T2DM). Blood tests will be performed to
investigate how the body processes the study drug and how the study drug affects the body.
For each participant, the study will last up to 24 weeks, inclusive of screening and will
include 10 visits to the study center.